Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: The CARMELA cross sectional study

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages 52-

  Escobedo, Jorge ^a,b   Schargrodsky, Herman ^c   Champagne, Beatriz ^d   Silva, Honorio ^e   Boissonnet, Carlos P ^f   Vinueza, Raul ^g   Torres, Marta ^f   Hernandez, Rafael ^h   Wilson, Elinor ⁱ  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Gabriel Mancera 222m Col Del Valle ^*  (Mexico)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^d InterAmerican Heart Foundation   (United States)

^e InterAmerican Foundation for Clinical Research   (United States)

^f CEMIC   (Argentina)

^g PFIZER INC   (United States)

^h UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

ⁱ UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE DISTRIBUTION; AGING; ARGENTINA; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CAROTID ATHEROSCLEROSIS; CHILE; CLINICAL ASSESSMENT; COLOMBIA; COMMON CAROTID ARTERY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECUADOR; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MEXICO; OBSERVATIONAL STUDY; PERU; PREVALENCE; SEX RATIO; SOUTH AND CENTRAL AMERICA; URBAN POPULATION; VENEZUELA;

ADULT; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LATIN AMERICA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 70449381588     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-52     Document Type: Article

References (35)

1. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH. The metabolic syndrome. Endocrine Rev 2008, 29:777-822.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
3. Eberly LE, Prineas R, Cohen JD, Vazquez G, Zhi X, Neaton JD, Kuller LH, . for the Multiple Risk Factor Intervention Trial Research Group Metabolic syndrome. Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial. Diabetes Care 2006, 29:123-130. 10.2337/diacare.29.01.06.dc05-1320, 16373907.
4. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250. 10.1161/01.CIR.0000140677.20606.0E, 15326067.
5. Nilsson PM, Engstrom G, Hedblad B. The metabolic syndrome and incidence of cardiovascular disease in non-diabetic subjects--a population-based study comparing three different definitions. Diabet Med 2007, 24:464-472. 10.1111/j.1464-5491.2007.02142.x, 17381496.
6. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 2005, 28:385-390. 10.2337/diacare.28.2.385, 15677797.
7. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778. 10.2337/diacare.28.7.1769, 15983333.
8. Empana JP, Duciemetiere P, Balkau B, Jouven X. Contribution of the metabolic syndrome to sudden death risk in asymptomatic men: the Paris Prospective Study I. Eur Heart J 2007, 28:1149-1154. 10.1093/eurheartj/ehm063, 17428821.
9. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC, Muggeo M. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome. Prospective data from the Bruneck Study. Diabetes Care 2003, 26:1251-1257. 10.2337/diacare.26.4.1251, 12663606.
10. Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab 2007, 32:23-32. 10.1139/H06-095, 17332782.
11. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci 2007, 333:362-371. 10.1097/MAJ.0b013e318065c3a1, 17570989.
12. Procopiou M, Philippe J. The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis 2005, 20(Suppl 1):2-8. 10.1159/000088231, 16276079.
13. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 2004, 27:2444-2449. 10.2337/diacare.27.10.2444, 15451914.
14. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, Silva H, Vinueza R, Silva-Ayçaguer LC, Touboul PJ, Boissonnet CP, Escobedo J, Pellegrini F, Macchia A, Wilson E, . for the CARMELA Study Investigators CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med 2008, 121:58-65. 10.1016/j.amjmed.2007.08.038, 18187074.
15. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23:75-80. 10.1159/000097034, 17108679.
16. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl 1):S5-S20.
17. Aguilar-Salinas CA, Rojas R, Gomez-Perez FJ, Valles V, Rios-Torres JM, Franco A, Olaiz G, Rull JA, Sepulveda J. High prevalence of metabolic syndrome in Mexico. Arch Med Res 2004, 35:76-81. 10.1016/j.arcmed.2003.06.006, 15036804.
18. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, González-Sánchez JL, Seclén S, Villena A, González-Villalpando C, Williams K, Haffner SM. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 2006, 29:685-691. 10.2337/diacare.29.03.06.dc05-1796, 16505527.
19. Florez H, Silva E, Fernandez V, Ryder E, Sulbaran T, Campos G, Calmon G, Clavel E, Castillo-Florez S, Goldberg R. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela. Diabetes Res Clin Pract 2005, 69:63-77. 10.1016/j.diabres.2004.11.018, 15955388.
20. Medina-Lezama J, Zea-Diaz H, Morey-Vargas OL, Bolaños-Salazar JF, Muñoz-Atahualpa E, Postigo-MacDowall M, Corrales-Medina F, Valdivia-Ascuña Z, Cuba-Bustinza C, Paredes-Díaz S, Villalobos-Tapia P, Chirinos-Pacheco J, Goldberg RB, Chirinos JA. Prevalence of the metabolic syndrome in Peruvian Andean hispanics: The PREVENCION study. Diabetes Res Clin Pract 2007, 78:270-281. 10.1016/j.diabres.2007.04.004, 17524517.
21. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Comparative Risk Assessment Collaborating Group. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med 2004, 1:e27. 10.1371/journal.pmed.0010027, 523844, 15526049.
22. Dallongeville J, Cottel D, Arveiler D, Tauber JP, Bingham A, Wagner A, Fauvel J, Ferrières J, Ducimetière P, Amouyel P. The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab 2004, 48:43-50. 10.1159/000075304, 14646340.
23. Mitrakou A. Women's health and the metabolic syndrome. Ann N Y Acad Sci 2006, 1092:33-48. 10.1196/annals.1365.003, 17308131.
24. Pramparo P, Schargrodsky H, Boissonnet C, Champagne BM, Silva H, Acevedo M, Wilson E. Cardiovascular risk factors for heart disease and stroke in women by age and time since menopause, in seven Latin American cities: The CARMELA Study. CVD Prev Control 2008, 3:181-189.
25. Hidalgo LA, Chedraui PA, Morocho N, Alvarado M, Chavez D, Huc A. The metabolic syndrome among postmenopausal women in Ecuador. Gynecol Endocrinol 2006, 22:447-454. 10.1080/09513590600890272, 17012107.
26. Royer M, Castelo-Branco C, Blumel JE, Chedraui PA, Danckers L, Bencosme A, Navarro D, Vallejo S, Espinoza MT, Gómez G, Izaguirre H, Ayala F, Martino M, Ojeda E, Onatra W, Saavedra J, Tserotas K, Pozzo E, Manriquez V, Prada M, Grandia E, Zuniga C, Lange D, Sayegh F, . Collaborative Group for Research of the Climacteric in Latin America The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007, 10:164-170.
27. Empana JP, Zureik M, Gariepy J, Courbon D, Dartigues JF, Ritchie K, Tzourio C, Alperovitch A, Ducimetiere P. The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study. Stroke 2007, 38:893-899. 10.1161/01.STR.0000257983.62530.75, 17272758.
28. Katakami N, Kaneto H, Matsuhisa M, Umayahara Y, Kosugi K, Yamasaki Y. Clustering of several cardiovascular risk factors affects tissue characteristics of the carotid artery. Atherosclerosis 2008, 198:208-213. 10.1016/j.atherosclerosis.2007.08.022, 17936288.
29. Martens FM, van der Graaf Y, Dijk JM, Olijhoek JK, Visseren FL. Carotid arterial stiffness is marginally higher in the metabolic syndrome and markedly higher in type 2 diabetes mellitus in patients with manifestations of arterial disease. Atherosclerosis 2008, 197:646-653. 10.1016/j.atherosclerosis.2007.02.019, 17374372.
30. Iglseder B, Cip P, Malaimare L, Ladurner G, Paulweber B. The metabolic syndrome is a stronger risk factor for early carotid atherosclerosis in women than in men. Stroke 2005, 36:1212-1217. 10.1161/01.STR.0000166196.31227.91, 15890992.
31. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, Kastelein JJ, Grobbee DE. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations?. Eur Heart J 2007, 28:398-406. 10.1093/eurheartj/ehl482, 17277033.
32. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467. 10.1161/CIRCULATIONAHA.106.628875, 17242284.
33. Gregory CO, Dai J, Ramirez-Zea M, Stein AD. Occupation is more important than rural or urban residence in explaining the prevalence of metabolic and cardiovascular disease risk in Guatemalan adults. J Nutr 2007, 137:1314-1319. 1904431, 17449598.
34. Albala C, Villarroel A, Santos JL, Angel B, Lera L, Liberman C, Sanchez H, Pérez-Bravo F. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders. Diabetes Res Clin Pract 2007, 77:245-250. 10.1016/j.diabres.2006.12.006, 17292994.
35. Smith SC, Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey. Curr Med Res Opin 2007, 23:29-47. 10.1185/030079906X159489, 17261236.